During this fireside chat Ben Shamsian, Vice President, Lytham Partners and Sean McGowan, Roth Capital Partners, chat with Rob Fried, Chief Executive Officer of ChromaDex Corporation. ChromaDex (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide...

read more